Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5912789 | Multiple Sclerosis and Related Disorders | 2014 | 7 Pages |
Abstract
Cognition changed in the early period following treatment but with little apparent relationship to volume changes. With temporal distance from the HSCT procedure, cognition returned to baseline levels. With the caution of a very small sample, preliminary results suggest that immunoablation and HSCT may have no lasting deleterious effects on cognition.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
L.A.S. Walker, J.A. Berard, H.L. Atkins, M. Bowman, H. Lee, M.S. Freedman,